Amidst internal upheaval at 23andMe, a shadow of unease falls upon its user base. The security of their most intimate data—their genetic blueprint— is now a pressing question. This anxiety is compounded by a turbulent corporate climate and a notable absence of comprehensive federal safeguards for such sensitive biological information. The roots of this distrust trace back to a...